Coronavirus Update: COVID-19 Funding Crisis For UK Medical Charities, Inovio Gets US Government Cash
Demand for charities' services soars but income plummets
UK medical research charities call for government assistance to temper damage caused by the pandemic, Inovio gets $71m in DOD contract to fund its vaccine, while ViralClear partners with Catalent to produce oral formulations of its antiviral merimepodib.
You may also be interested in...
Coronavirus Update: Spooked By America’s COVID-19 Vaccine Skepticism, FDA Promises Not To Lower Standards
The FDA has released detailed guidance to COVID-19 vaccine manufacturers setting out the safety and efficacy standards required, and pledged to not cut corners.
Merck pays undisclosed upfront fees and promises up to $500m for milestones under licensing and collaboration agreement. Meanwhile, Tetraphase and Xerava are being acquired by La Jolla, after previous bids by Melinta and AcelRx.
Progress for two US-based companies in the race to develop a COVID-19 vaccine.